User profiles for Davide Corti
 | Davide CortiSVP Antibody Research Verified email at humabs.ch Cited by 33894 |
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerged
coronavirus that is responsible for the current pandemic of coronavirus disease 2019 (COVID-19), …
coronavirus that is responsible for the current pandemic of coronavirus disease 2019 (COVID-19), …
Exceptionally potent human monoclonal antibodies are effective for prophylaxis and treatment of tetanus in mice
We used human monoclonal antibodies (humAbs) to study the mechanism of neuron
intoxication by tetanus neurotoxin and to evaluate these antibodies as a safe preventive and …
intoxication by tetanus neurotoxin and to evaluate these antibodies as a safe preventive and …
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
The recently emerged SARS-CoV-2 Omicron variant encodes 37 amino acid substitutions in
the spike protein, 15 of which are in the receptor-binding domain (RBD), thereby raising …
the spike protein, 15 of which are in the receptor-binding domain (RBD), thereby raising …
Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface
G Di Zenzo, G Di Lullo, D Corti… - The Journal of …, 2012 - Am Soc Clin Investig
Pemphigus vulgaris (PV) is an autoimmune blistering disease of skin and mucous membranes
caused by autoantibodies to the desmoglein (DSG) family proteins DSG3 and DSG1, …
caused by autoantibodies to the desmoglein (DSG) family proteins DSG3 and DSG1, …
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals
D Corti, JPM Langedijk, A Hinz, MS Seaman… - PloS one, 2010 - journals.plos.org
Background The isolation of human monoclonal antibodies (mAbs) that neutralize a broad
spectrum of primary HIV-1 isolates and the characterization of the human neutralizing …
spectrum of primary HIV-1 isolates and the characterization of the human neutralizing …
SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
…, AJ Fisher, MS Pizzuto, A de Marco, D Corti… - Nature, 2022 - nature.com
The SARS-CoV-2 Omicron BA.1 variant emerged in 2021 1 and has multiple mutations in its
spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for …
spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for …
An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
The emergence of the highly transmissible B.1.1.529 Omicron variant of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody countermeasure …
respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody countermeasure …
[PDF][PDF] Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology
Analysis of the specificity and kinetics of neutralizing antibodies (nAbs) elicited by SARS-CoV-2
infection is crucial for understanding immune protection and identifying targets for …
infection is crucial for understanding immune protection and identifying targets for …
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …
